0 items USD 0.00Search
Your search for "current partnering breast cancer partnering 2009 2014" gave back 36850 results.
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Summary Vinblastinesulphate (CAS 143-67-9) market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
June 2019
Price: USD 2,960.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Highlights The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The “B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Forecast” looks at past sales and reviews total world B-Cell Maturation Antigen (...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market The global B-Cell Maturation Antigen (BCMA) Targeted...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
